Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit

Video   Jul 07, 2015


Molecular imaging is increasingly being used to support decision-making in early-stage drug development, particularly in the CNS. Providing invaluable information on the so-called ‘three pillars of drug survival’, namely tissue delivery, target engagement and pharmacological effect, it can be seen as a kind of precision pharmacology However, a lack of appreciation of when and how to use imaging and a lack of suitable tools means imaging is often an afterthought and employed in a post-mortem of drug failure. Timely development of imaging biomarkers will ensure the full translational value of this technology can be realised 


Recommended Videos

How Does Your Body Process Medicine?


Have you ever wondered what happens to a painkiller, like ibuprofen, after you swallow it? Medicine that slides down your throat can help treat a headache, a sore back, or a throbbing sprained ankle. But how does it get where it needs to go in the first place?


Behind the Science, S2 Ep 11: Jeremy Shia on sample cleanup for testing for pesticides in spinach


Jeremy Shia shows Jen Fournier the options for removing chlorophyll from QuEChERS spinach extracts prior to GC-MS/MS analysis.


Morphologi 4-ID in action - Morphologically-Directed Raman Spectroscopy Technology


Morphologically-Directed Raman Spectroscopy (MDRS) combining automated imaging and chemical identification for advanced particle characterization.



Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free